[Anti-angiogenic reagents].
Shibuya
M
M
Department of Genetics, University of Tokyo, Japan. shibuya@ims.u-tokyo.ac.jp
D020533:Angiogenesis Inhibitors; D000818:Animals; D000911:Antibodies, Monoclonal; D003930:Diabetic Retinopathy / Q000188:drug therapy / Q000209:etiology; D015195:Drug Design; D016228:Endothelial Growth Factors / Q000276:immunology / Q000502:physiology; D006801:Humans; D008222:Lymphokines / Q000276:immunology / Q000502:physiology; D009369:Neoplasms / Q000188:drug therapy / Q000209:etiology; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors; D020794:Receptor Protein-Tyrosine Kinases / Q000276:immunology / Q000502:physiology; D017978:Receptors, Growth Factor / Q000276:immunology / Q000502:physiology; D040262:Receptors, Vascular Endothelial Growth Factor; D015398:Signal Transduction; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors
D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D016228:Endothelial Growth Factors; D008222:Lymphokines; D017978:Receptors, Growth Factor; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors; D011505:Protein-Tyrosine Kinases; D020794:Receptor Protein-Tyrosine Kinases; D040262:Receptors, Vascular Endothelial Growth Factor